Holen Sie sich die Stockscreener-App
15.06
0.40%
0.06
Handel nachbörslich:
15.05
-0.010
-0.07%
Finanzdaten der Benitec Biopharma Inc-Aktie (BNTC)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
18.33%
10.19
|
8.61 | 5.791 | 5.548 | 4.141 |
| Operating Income/Loss |
18.33%
-10.19
|
-8.61 | -5.791 | -5.548 | -4.141 |
| Nonoperating Income/Loss |
33.44%
0.834
|
1.253 | 0.732 | 0.828 | -0.138 |
| Income/Loss From Continuing Operations Before Tax |
27.14%
-9.354
|
-7.357 | -5.059 | -4.72 | -4.279 |
| Income/Loss From Continuing Operations After Tax |
27.14%
-9.354
|
-7.357 | -5.059 | -4.72 | -4.279 |
|
Net Income/Loss
|
27.14%
-9.354
|
-7.357 | -5.059 | -4.72 | -4.279 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | 0.619 | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
74.85%
38.60
|
22.08 | 10.64 | 1.6109 | 2.6163 |
| Diluted Average Shares |
74.85%
38.60
|
22.08 | 10.64 | 1.6109 | 2.6163 |
| Basic Earnings Per Share |
27.27%
-0.24
|
-0.33 | -0.48 | 1.70 | -1.64 |
| Diluted Earnings Per Share |
27.27%
-0.24
|
-0.33 | -0.48 | 1.70 | -1.64 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | 0.619 | - |
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):